Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesmary Modugno

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Obstetrics and Gynecology|April 2, 2005
Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancerJulia B Greer, Francesmary Modugno, Glenn O Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Endometriosis and its treatment with danazol or lupron in relation to ovarian cancerCarrie M Cottreau, Roberta B Ness, Francesmary Modugno, et al.
Cancer Causes & Control : CCC|February 22, 2021
Gestational weight gain and risk of epithelial ovarian cancerZhuxuan Fu, Joseph L Kelley, Kunle Odunsi, et al.
JAMA Network Open|July 16, 2024
Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast CancerChao Cai, Kaowao Strickland, Sophia Knudsen, et al.
The Breast Journal|May 23, 2018
Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiationSergey Melnov, Patricia Murphy, Thomas Foley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2004
Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposureAnita S Y Sit, Francesmary Modugno, Lyndon M Hill, et al.
Endocrine-Related Cancer|October 10, 2012
Hormone response in ovarian cancer: time to reconsider as a clinical target?Francesmary Modugno, Robin Laskey, Ashlee L Smith, et al.
Infectious Agents and Cancer|February 12, 2009
Leptin levels and leptin receptor polymorphism frequency in healthy populationsCamille C Ragin, Cher Dallal, Michael Okobia, et al.
Gynecologic Oncology|July 30, 2002
Hormone replacement therapy formulations and risk of epithelial ovarian carcinomaAnita S Y Sit, Francesmary Modugno, Joel L Weissfeld, et al.
The International Journal of Biological Markers|April 9, 2013
Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional studyCher Dallal, Seymour Garte, Camille Ragin, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Obstetrics and Gynecology|April 2, 2005
Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancerJulia B Greer, Francesmary Modugno, Glenn O Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Endometriosis and its treatment with danazol or lupron in relation to ovarian cancerCarrie M Cottreau, Roberta B Ness, Francesmary Modugno, et al.
Cancer Causes & Control : CCC|February 22, 2021
Gestational weight gain and risk of epithelial ovarian cancerZhuxuan Fu, Joseph L Kelley, Kunle Odunsi, et al.
JAMA Network Open|July 16, 2024
Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast CancerChao Cai, Kaowao Strickland, Sophia Knudsen, et al.
The Breast Journal|May 23, 2018
Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiationSergey Melnov, Patricia Murphy, Thomas Foley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2004
Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposureAnita S Y Sit, Francesmary Modugno, Lyndon M Hill, et al.
Endocrine-Related Cancer|October 10, 2012
Hormone response in ovarian cancer: time to reconsider as a clinical target?Francesmary Modugno, Robin Laskey, Ashlee L Smith, et al.
Infectious Agents and Cancer|February 12, 2009
Leptin levels and leptin receptor polymorphism frequency in healthy populationsCamille C Ragin, Cher Dallal, Michael Okobia, et al.
Gynecologic Oncology|July 30, 2002
Hormone replacement therapy formulations and risk of epithelial ovarian carcinomaAnita S Y Sit, Francesmary Modugno, Joel L Weissfeld, et al.
The International Journal of Biological Markers|April 9, 2013
Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional studyCher Dallal, Seymour Garte, Camille Ragin, et al.
Pageof 21